We now have 13 clinical studies supporting the use of Lab4 probiotics for a variety of functions in adults, children and babies. Carried out over the past 15 years, these studies have shown the benefit of the Lab4 and Lab4b consortia in supporting digestive health, immune health, performance and mood and cognition.
Specifically, the studies have shown the impact of probiotics on early immune system development, immunity in children, alongside antibiotics and in helping to prevent antibiotic resistance, irritable bowel syndrome (IBS), athletic performance, anxiety and attention.
Throughout these trials and 15 years of use in products, the Lab4 probiotic bacteria have been shown to be completely safe. This is further supported by The Swansea Baby Trial which involved both pregnant ladies and newborn babies. The approval of the Lab4b probiotics for use in this large trial with these two potentially vulnerable populations is testament to the efficacy of this group of bacteria.